Support Programs to Help Make Ig Therapy Accessible and Affordable

Welcome to Hizentra Connect, a comprehensive resource center for healthcare providers (HCPs) and people who depend on CSL Behring's immune globulin (Ig) therapies.

IgIQ logo

To get the guidance and support you need, call
1-877-355-4447
Monday–Friday, 8 AM to 8 PM ET

How can Hizentra Connect help?

Copay icon

Copay


  • Helps the majority of patients with commercial insurance pay $0 out-of-pocket for Hizentra*
  • Patients can contact CSL Behring's Hizentra Connect Resource Center at 1-877-355-4447 to learn more.
* Subject to terms and conditions of the copay assistance program. To read the full terms and conditions, visit cslbehring.com/patients/support-and-assistance. CSL Behring reserves the right to rescind, revoke, or amend the program at any time without notice.
Assurance icon

Assurance


A gap in insurance shouldn't mean a gap in treatment. CSL Behring understands the stress and hardship caused by a lapse in health insurance. Assurance is designed to help eligible patients, who rely on our Ig therapies, continue to receive treatment even if they experience a lapse in third-party, private health insurance.

Benefits for Patients

Assurance allows patients to build up a reserve of Hizentra at no additional cost. This can be used in the event of a lapse in insurance coverage, so it's important to enroll as soon as possible.*

Advantage for HCPs

Assurance helps to keep patients on track with their treatment protocol during difficult times.

*Enrollment required. Subject to terms and conditions. For the Assurance program, visit cslbehringassurance.com.
Premier Start℠ Sample icon

Patient Assistance Program


  • Provides access to therapies for qualified patients who are uninsured or underinsured

Learn more about the Patient Assistance Program.

book icon

Medicare Coverage


Hizentra is covered under Medicare Part B.*

The convenience of self-infused Hizentra—covered under the same benefit category as IVIg.

Lower patient out-of-pocket cost than with Part D

  • Coverage includes infusion pump, ancillary supplies, medication, and nurse training

No prior authorization required

For updated coverage and comprehensive support, call Hizentra Connect at 1-877-355-4447, Monday–Friday, 8 AM to 8 PM ET.

*100% coverage for those with Medicare Part B and a Medigap plan after Part B annual deductible is met. Coverage of IVIg when administered in a clinical setting. Chart notes must be up to date and include diagnostic criteria.
Voice2Voice icon

Voice2Voice®


  • A unique program that connects PI and CIDP patients and caregivers with people who have direct experience with Hizentra therapy
  • Offers peer-to-peer support, resources, and encouragement*

Voice2Voice
*Voice2Voice advocates are not healthcare professionals or medical experts. For medical questions, patients should contact their healthcare provider. Voice2Voice advocates are compensated by CSL Behring LLC for their time and/or expenses.
Free Trial icon

Free Trial


  • Provides a one-month supply of product, infusion equipment, and training at no cost to your patient
  • Free in-home visits by a trained nurse who will teach patients how to infuse Hizentra
  • Seamless process, from trial and request to follow-up therapy notes provided to your office and the patient's pharmacy
Reimbursement icon

Reimbursement Support


  • Prior authorizations, appeals, and connection to CSL Behring's field reimbursement team
Hizentra Connect logo

To get the guidance and support you need, call
1-877-355-4447
Monday–Friday, 8 AM to 8 PM ET

Get in touch to learn more

Along with the support offered by the knowledgeable staff of Hizentra Connect, your Hizentra representative can also serve as a valuable resource for information about PI and SCIg treatment. Please feel free to utilize their expertise.

Request more information about Hizentra

Of course, a lot of useful information is at your fingertips through this site right now, including Access and Billing Codes and Patient Resources.

acuity
You are now leaving the current website.

Do you want to continue?

No Yes